NL8501829A - Glutaminezuur- respectievelijk asparaginezuurderivaten, werkwijze voor de bereiding ervan alsmede de toepassing ervan in preparaten. - Google Patents

Glutaminezuur- respectievelijk asparaginezuurderivaten, werkwijze voor de bereiding ervan alsmede de toepassing ervan in preparaten. Download PDF

Info

Publication number
NL8501829A
NL8501829A NL8501829A NL8501829A NL8501829A NL 8501829 A NL8501829 A NL 8501829A NL 8501829 A NL8501829 A NL 8501829A NL 8501829 A NL8501829 A NL 8501829A NL 8501829 A NL8501829 A NL 8501829A
Authority
NL
Netherlands
Prior art keywords
formula
compounds
compound
activity
treatment
Prior art date
Application number
NL8501829A
Other languages
English (en)
Dutch (nl)
Original Assignee
Rotta Research Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT67644/84A external-priority patent/IT1178982B/it
Priority claimed from IT68070/84A external-priority patent/IT1196751B/it
Application filed by Rotta Research Lab filed Critical Rotta Research Lab
Publication of NL8501829A publication Critical patent/NL8501829A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL8501829A 1984-06-25 1985-06-25 Glutaminezuur- respectievelijk asparaginezuurderivaten, werkwijze voor de bereiding ervan alsmede de toepassing ervan in preparaten. NL8501829A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT67644/84A IT1178982B (it) 1984-06-25 1984-06-25 Derivati del acido gludamico aventi attivita antagonista su polipep tidi bioattivi e procedimento per la loro preparazione
IT6764484 1984-06-25
IT68070/84A IT1196751B (it) 1984-10-26 1984-10-26 Alogeno e ciano derivati dell'acido glutammico ed aspartico ad attivita antagonista su polipeptidi bioattivi e procedimento per la loro preparazione
IT6807084 1984-10-26

Publications (1)

Publication Number Publication Date
NL8501829A true NL8501829A (nl) 1986-01-16

Family

ID=26329809

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8501829A NL8501829A (nl) 1984-06-25 1985-06-25 Glutaminezuur- respectievelijk asparaginezuurderivaten, werkwijze voor de bereiding ervan alsmede de toepassing ervan in preparaten.

Country Status (15)

Country Link
US (1) US4791215A (de)
AT (1) AT390949B (de)
AU (1) AU566601B2 (de)
BE (1) BE902726A (de)
CA (1) CA1325633C (de)
CH (1) CH674203A5 (de)
DE (1) DE3522506A1 (de)
DK (1) DK285685A (de)
ES (1) ES8604859A1 (de)
FR (1) FR2566397B1 (de)
GB (1) GB2160869B (de)
IE (1) IE57892B1 (de)
NL (1) NL8501829A (de)
NZ (1) NZ212436A (de)
SE (1) SE503111C2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215169B (it) * 1985-12-17 1990-01-31 Rotta Research Lab Derivati alchil ossigenati degli acidi glutammico ed aspartico ad attivita antagonista su polipeptidi bioattivi e procedimento per la loro preparazione
US5089638A (en) * 1986-06-16 1992-02-18 Merck & Co., Inc. Amino acid analogs as CCK-antagonists
US4880938A (en) * 1986-06-16 1989-11-14 Merck & Co., Inc. Amino acid analogs
IT1196849B (it) * 1986-12-16 1988-11-25 Rotta Research Lab Nuovi derivati degli acidi 5 pentilammino 5 oxo pentaoico e 4 pentilammino 4 oxo butanoico ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
IT1217123B (it) * 1987-02-05 1990-03-14 Rotta Research Lab Derivati otticamente attivi dell acido 5 pentilammino 5 oxo pentanoico r ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
US4971978A (en) * 1987-09-21 1990-11-20 Nadzan Alex M Derivatives of D-glutamic acid and D-aspartic acid
JPH06504031A (ja) * 1988-09-30 1994-05-12 オーストレイリアン・コマーシヤル・リサーチ・アンド・デイベロツプメント・リミテツド アミノ酸輸送蛋白質、アミノ酸アナログ、アッセイ装置並びにその癌の治療及び診断への使用
FR2643371B1 (fr) * 1989-02-17 1993-11-05 Roussel Uclaf Nouveaux derives de l'acide 2-amino pentanedioique, leur procede de preparation et leur application comme medicaments
EP0727215A3 (de) * 1989-08-04 1996-11-06 Merck Sharp & Dohme Zentrale Cholecystokinin-Antagonisten zur Behandlung von psychiatrischen Krankheiten
IE912285A1 (en) * 1990-07-12 1992-01-15 Black James Foundation Amino acid derivatives
IT1241029B (it) * 1990-12-11 1993-12-27 Rotta Research Lab Derivati amidici biciclici e policiclici degli acidi glutammico, aspartico e 2-ammino adipico ad attivita' antigastrinica e procedimento per la loro preparazione
US5153191A (en) * 1991-08-20 1992-10-06 Warner-Lambert Company Cholecystokinin antagonists useful for treating depression
US5217957A (en) * 1991-08-20 1993-06-08 Warner-Lambert Company Cholecystokinin antagonists useful for treating depression
JPH07507993A (ja) * 1991-12-20 1995-09-07 メルク シヤープ エンド ドーム リミテツド 医薬活性を有する中枢神経系コレシストキニンアンタゴニスト
US5716958A (en) * 1994-10-27 1998-02-10 Tobishi Pharmaceutical Co., Ltd. Amino acid derivative having anti-CCK activity
GB9721746D0 (en) * 1997-10-15 1997-12-10 Panos Therapeutics Limited Compositions
CN102274130B (zh) * 2003-11-27 2013-06-12 株式会社资生堂 N-苯磺酰基-l-谷氨酸或其盐的应用
CN108912007B (zh) * 2018-06-20 2021-02-26 中国农业科学院兰州畜牧与兽药研究所 一种右氯谷胺的制备方法
CN110325052B (zh) * 2018-11-05 2022-11-18 彭险峰 天门冬氨酸脂肪酰基衍生物在制备动物饲料添加剂中的应用
US11964929B2 (en) 2018-12-18 2024-04-23 Wisorig Technologies Pte. Limited Application of glutamine derivative in preparation of animal feed additive
US20220304352A1 (en) * 2019-08-15 2022-09-29 Firmenich Sa Taste-modifying compounds and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2828327A (en) * 1953-12-17 1958-03-25 Monsanto Chemicals Esters of n-aroylaspartic acids
US3551419A (en) * 1964-07-31 1970-12-29 Rotta Research Lab Amino acid amides and process for their production
JPS5111608B2 (de) * 1972-06-07 1976-04-13

Also Published As

Publication number Publication date
IE57892B1 (en) 1993-05-05
SE503111C2 (sv) 1996-03-25
AT390949B (de) 1990-07-25
CH674203A5 (de) 1990-05-15
DE3522506C2 (de) 1988-03-10
ATA186985A (de) 1990-01-15
GB2160869A (en) 1986-01-02
US4791215A (en) 1988-12-13
SE8503097D0 (sv) 1985-06-20
CA1325633C (en) 1993-12-28
FR2566397A1 (fr) 1985-12-27
BE902726A (fr) 1985-10-16
DE3522506A1 (de) 1986-01-02
GB2160869B (en) 1988-03-16
FR2566397B1 (fr) 1988-08-05
SE8503097L (sv) 1985-12-26
ES8604859A1 (es) 1986-03-16
AU566601B2 (en) 1987-10-22
DK285685A (da) 1985-12-26
IE851502L (en) 1985-12-22
ES544462A0 (es) 1986-03-16
AU4410985A (en) 1986-01-02
DK285685D0 (da) 1985-06-24
GB8515555D0 (en) 1985-07-24
NZ212436A (en) 1989-04-26

Similar Documents

Publication Publication Date Title
NL8501829A (nl) Glutaminezuur- respectievelijk asparaginezuurderivaten, werkwijze voor de bereiding ervan alsmede de toepassing ervan in preparaten.
JP2007536243A (ja) ホスホリパーゼ−a2阻害薬を用いた、高コレステロール血症、高トリグリセリド血症、心臓血管疾患の治療
US5776972A (en) Kappa-opiate agonists for inflammatory bowel disorders
US9447040B2 (en) Tricyclic compounds, compositions comprising them and uses thereof
Delvaux Pharmacology and clinical experience with fedotozine
CN113993546A (zh) 使用葫芦巴碱和维生素预防或治疗骨骼肌病症或障碍的组合物和方法
IE58722B1 (en) Improved antiinflammatory salts of piroxicam
US20140080875A1 (en) 3,4-diaminopyridine tartrate and phosphate, pharmaceutical compositions and uses thereof
EP4126004A1 (de) Agonistenkombination
US20120071458A1 (en) Methods for treating obesity
EP0286643B1 (de) Pharmazeutisch aktive derivate von glutamin- und asparaginsäuren
CN104447611A (zh) 阿考替胺化合物
BR112019010564A2 (pt) composição e uso de uma composição
KR102079065B1 (ko) 데하이드로-6-진저디온을 포함하는 대사성 질환 예방 또는 치료용 약학 조성물
US10568852B2 (en) Combination compositions and their use in methods for treating obesity and obesity-related disorders
CN103980148B (zh) 硬脂酰氨基酸盐及其制备方法和应用
CN108250219B (zh) 一种治疗甲状腺炎的药物及其制备方法
CN114072147A (zh) 使用葫芦巴碱和高蛋白质来预防或治疗骨骼肌病症或障碍的组合物和方法
WO2010098298A1 (ja) 栄養素の消化吸収抑制作用を有する化合物とシクロヘキサンカルボキサミド誘導体を組み合わせてなる医薬組成物
WO2021194153A1 (ko) 섬유화 질환 복합 치료제 개발
KR102375161B1 (ko) 섬유화 질환 치료용 복합 약학 조성물
WO2021079987A1 (ja) 筋質向上剤
CN114126630A (zh) 使用葫芦巴碱和矿物质来预防或治疗骨骼肌病症或障碍的组合物和方法
WO2022140279A1 (en) Synergistic modulators of alpha-dicarbonyl detoxification and their use for inducing weight loss and the treatment of diabetic pathologies
KR20010013274A (ko) 2-(4-(4-(4,5-디클로로-2-메틸이미다졸-1-일)부틸)-1-피페라지닐)-5-플루오로피리미딘, 이것의 제조 방법 및 이것의치료적 용도

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed